CN102816146A - 甲磺酸氟马替尼晶型a及其制备方法和用途 - Google Patents
甲磺酸氟马替尼晶型a及其制备方法和用途 Download PDFInfo
- Publication number
- CN102816146A CN102816146A CN2011101628974A CN201110162897A CN102816146A CN 102816146 A CN102816146 A CN 102816146A CN 2011101628974 A CN2011101628974 A CN 2011101628974A CN 201110162897 A CN201110162897 A CN 201110162897A CN 102816146 A CN102816146 A CN 102816146A
- Authority
- CN
- China
- Prior art keywords
- crystal form
- methylsulfonic acid
- acid fluorine
- preparation
- fluorine imatinib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101628974A CN102816146A (zh) | 2011-06-10 | 2011-06-10 | 甲磺酸氟马替尼晶型a及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101628974A CN102816146A (zh) | 2011-06-10 | 2011-06-10 | 甲磺酸氟马替尼晶型a及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102816146A true CN102816146A (zh) | 2012-12-12 |
Family
ID=47300638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101628974A Pending CN102816146A (zh) | 2011-06-10 | 2011-06-10 | 甲磺酸氟马替尼晶型a及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102816146A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109400583A (zh) * | 2017-08-17 | 2019-03-01 | 江苏豪森药业集团有限公司 | 甲磺酸氟马替尼晶型β及其制备方法和用途 |
CN109400582A (zh) * | 2017-08-17 | 2019-03-01 | 江苏豪森药业集团有限公司 | 甲磺酸氟马替尼晶型α及其制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1939910A (zh) * | 2004-12-31 | 2007-04-04 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
CN1972917B (zh) * | 2004-12-31 | 2010-08-25 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
-
2011
- 2011-06-10 CN CN2011101628974A patent/CN102816146A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1939910A (zh) * | 2004-12-31 | 2007-04-04 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
CN1972917B (zh) * | 2004-12-31 | 2010-08-25 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
Non-Patent Citations (1)
Title |
---|
GANG XU ET AL.: "SYNTHESIS, CRYSTAL STRUCTURE, AND SPECTRAL CHARACTERIZATION OF FLUMATINIB MESYLATE", 《SYNTHETIC COMMUNICATIONS》, vol. 40, no. 17, 5 August 2010 (2010-08-05), pages 2564 - 2570, XP008129293 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109400583A (zh) * | 2017-08-17 | 2019-03-01 | 江苏豪森药业集团有限公司 | 甲磺酸氟马替尼晶型β及其制备方法和用途 |
CN109400582A (zh) * | 2017-08-17 | 2019-03-01 | 江苏豪森药业集团有限公司 | 甲磺酸氟马替尼晶型α及其制备方法和用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102636384B1 (ko) | 스플라이싱을 조절하는 방법 및 조성물 | |
ES2802296T3 (es) | Co-cristales de (S)-N-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolin-4-carboxamida y derivados deuterados de la misma como inhibidores de DNA-PK | |
CN102131801B (zh) | 1,2-二取代的杂环化合物 | |
EP3049412B1 (en) | New 3-(1h-pyrazol-4-yl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors | |
US10005776B2 (en) | Compounds as NIK inhibitors | |
CN102459242B (zh) | 苯氧基甲基杂环化合物 | |
CN107787226A (zh) | 药物组合 | |
US20180086739A1 (en) | Plk4 inhibitors | |
CN104364248B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN111362925B (zh) | 一种4-嘧啶甲酰胺类化合物、药物组合物、制备方法及应用 | |
CN108430978A (zh) | 3-羟基-喹唑啉-2,4-二酮衍生物及其作为核酸酶调节剂的用途 | |
CN102816146A (zh) | 甲磺酸氟马替尼晶型a及其制备方法和用途 | |
Berabez et al. | LIM kinases, promising but reluctant therapeutic targets: chemistry and preclinical validation in vivo | |
CN103509007B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN105198860A (zh) | 新的甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN104672210B (zh) | 阿格列汀和苯甲酸阿格列汀的制备方法 | |
CN102816147A (zh) | 甲磺酸氟马替尼晶型b及其制备方法和用途 | |
CN103509006B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN104974139B (zh) | 甲磺酸氟马替尼新晶型及其制备方法和医药用途 | |
CN105175285A (zh) | 多靶点型他米巴罗汀衍生物及其制备方法和应用 | |
CN104622874A (zh) | Ccr4拮抗剂在抑制癌生长及转移中的应用 | |
CN105722836A (zh) | 3,5-二氨基吡唑激酶抑制剂的药学上可接受的盐 | |
CN106188006A (zh) | 含1,2,3三氮唑杂环类化合物及其制备方法和应用 | |
CN105985319A (zh) | 芳基酞嗪化合物及其制备方法和用途 | |
CN109846818B (zh) | 一种具有乌苯美司结构的抗肿瘤药物的注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant before: Jiangsu Hansoh Pharmaceutical Group Lianyungang Hongchuang Medical Co., Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160315 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121212 |